Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.
about
Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complicationsWSES guidelines for management of Clostridium difficile infection in surgical patientsClostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic reviewPseudomembranous colitisRisk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic reviewTrends in Clostridium difficile Disease: Epidemiology and InterventionNosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionUpdate on Clostridium difficile infection.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.Clinical review of the management of fulminant clostridium difficile infection.Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens.Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.Identification and characterization of a gene cluster required for proper rod shape, cell division, and pathogenesis in Clostridium difficile.Drug-induced diarrhoea.The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.Do probiotics have a therapeutic role in gastroenterology?Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD.The potential value of Clostridium difficile vaccine: an economic computer simulation model.Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrheaMicroecologic approaches for traveler's diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea.Clinical predictors of recurrent Clostridium difficile infection in out-patients.In vitro activity of OPT-80 against Clostridium difficile.Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USAProbiotics in clostridium difficile Infection.Treatment of Clostridium difficile Infection.Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infectionPreclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii.The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea.A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic LocationsNovel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies.Treatment of Clostridium difficile-associated diarrhea.Clostridium difficile in long-term-care facilities for the elderly.A prediction model for Clostridium difficile recurrenceClostridium difficile in the Long-Term Care Facility: Prevention and ManagementRisk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonizationColonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.Recurrent Clostridium difficile infection and the microbiome.
P2860
Q24542134-E58A3BC2-EACE-49A9-9966-52B799795DCCQ26795429-08178E58-AD89-4E89-9BC4-55C06D1EFDD5Q26827693-11AA65AC-8942-4376-BC3F-CF5FCB34BAF0Q26865999-C74AE08C-0086-495D-8E99-B19CDA495174Q27021390-8C63EAF6-9E12-47F8-A4A4-A6B336208B35Q28655729-A132A986-99D5-4832-A8EF-A87E0DB26793Q28658118-A3CF2DAC-D50D-4230-8A8E-EF3782CE6E1CQ30306041-57BDDA7D-E943-4D37-8E8C-63513D102FBEQ33214954-B89F5D8A-310F-4352-9868-C0E2A85D2B1AQ33375824-D9ABAC1A-B4E9-4F1D-97B9-77A80538DDC6Q33712691-5D5C55E3-51B2-4C70-80E2-5CF37ECD7976Q33729925-69C77E94-462B-4A27-B398-E9EA9EFB83B9Q33743243-1627EF03-A513-437C-90BB-551819FBBA8FQ33824847-8BF6A651-EEC3-4B31-A78C-2878D740C3EAQ33838644-1C53A698-C7D6-4AFD-98C9-C845F206C017Q33869477-B6A99865-1493-4544-85E6-9F93EE0BEF8FQ33964245-A89AB8C1-7B5D-4981-851E-DD1636469D1CQ34012314-6FA9A7F0-1371-45C3-A66D-8BFB65964038Q34018277-6DD5DF08-69DC-44A3-A542-4D5AE7A3907FQ34027770-734EDCF1-7E0D-4E02-BF51-51D562CBCC0EQ34055615-072E2DFA-39CB-485C-95F5-1D57E4B295D5Q34142125-158974B1-92BB-40EF-9EAC-176D5CC36F50Q34216237-AC605244-9DF6-4DBD-B48D-455C4E35BAD4Q34223543-B2DA3452-EC18-44BB-BD47-375A531C8C9DQ34321534-527AE6EB-7EDA-471A-817F-6427F610F1D8Q34331045-4A588A59-A07E-4D1B-81D6-48C62DFA9100Q34472684-79ECBC72-8AE7-4DE7-A888-8D37F4EC368FQ34609154-A2231BA2-C5AF-49DD-9B64-E25540F207C9Q34643123-0CC4C569-9C7F-4713-9AD1-9F41F6F9CB96Q34767730-21B9718A-9934-41E5-AD75-E88A9CCD2C41Q34801846-40D1602C-4F09-45B5-B803-8D726732B2E6Q34801881-60BFE9D4-56F4-43F7-8C73-6BF7F52F78FEQ34979678-601E0BFD-3FB4-41FE-9802-65BA8B0F23ECQ35009239-837070B6-4257-4B4A-810D-03890C1A75DFQ35054817-B3C897E6-1C1E-48C9-887E-858FA49AFF8CQ35065783-1C1D2271-AC1C-4822-B348-C62F16857583Q35072513-1198DCE9-1F23-4AFB-B059-25604FF5C924Q35587936-01B3E517-8DF4-4F77-B2F2-C425332F1A9FQ35596453-0FB74B13-F118-40DD-AAC1-254F81BE5344Q35685694-82190922-3FA6-4810-BD96-22693B7201FA
P2860
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Recurrent Clostridium difficil ...... domized, double-blinded trial.
@en
type
label
Recurrent Clostridium difficil ...... domized, double-blinded trial.
@en
prefLabel
Recurrent Clostridium difficil ...... domized, double-blinded trial.
@en
P2093
P356
P1476
Recurrent Clostridium difficil ...... domized, double-blinded trial.
@en
P2093
Greenberg RN
McFarland LV
Mulligan ME
Surawicz CM
P304
P356
10.1093/CLINIDS/24.3.324
P407
P577
1997-03-01T00:00:00Z